Show
Sort by
-
Goals of treatment for improved survival in primary biliary cholangitis : treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase
-
Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis : risk factors and time trends in incidence and outcome
-
Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing
-
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment
-
Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases : a single-center cohort study
-
Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis
-
Candida albicans colonization and ASCA in familial Crohn's disease
-
Single-dose crossover pharmacokinetic/pharmacodynamic study of fospropofol vs propofol in healthy volunteers
-
Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers
-
Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease